AIM
Alerce Investment Management Portfolio holdings
AUM
$56.8M
This Quarter Return
-17.03%
1 Year Return
+31.17%
3 Year Return
+25.12%
5 Year Return
–
10 Year Return
–
AUM
$254M
AUM Growth
–
Cap. Flow
+$254M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
7
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
American Well
AMWL
|
$160M |
| 2 |
Annexon
ANNX
|
$48.9M |
| 3 |
Assembly Biosciences
ASMB
|
$13.5M |
| 4 |
Akebia Therapeutics
AKBA
|
$13M |
| 5 |
RNTX
Rein Therapeutics, Inc. Common Stock
RNTX
|
$7.91M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
American Well
AMWL
$111M
| $160M | 62.85% | +6,300,773 | New | +$160M |
|
|
2
Annexon
ANNX
$226M
| $48.9M | 19.27% | +1,954,978 | New | +$48.9M |
|
|
3
Assembly Biosciences
ASMB
$190M
| $13.5M | 5.31% | +2,227,500 | New | +$13.5M |
|
|
4
Akebia Therapeutics
AKBA
$833M
| $13M | 5.13% | +4,652,561 | New | +$13M |
|
|
RNTX
5
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $7.91M | 3.12% | +7,609,449 | New | +$7.91M |
|
|
WHWK
6
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.1M
| $5.51M | 2.17% | +5,621,835 | New | +$5.51M |
|
|
GBT
7
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $5.47M | 2.15% | +126,270 | New | +$5.47M |
|